EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

GMP-like and MLP-like Subpopulations of Hematopoietic Stem and Progenitor Cells Harboring Mutated EZH2 and TP53 at Diagnosis Promote Acute Myeloid Leukemia Relapse: Data of Combined Molecular, Functional, and Genomic Single-Stem-Cell Analyses

Tal Shahar Gabay, Nofar Stolero, Niv Rabhun iD, Rawan Sabah, Ofir Raz, Yaara Neumeier iD, Zipora Marx, Liming Tao, Tamir Biezuner, Shiran Amir, Rivka Adar, Ron Levy und 6 weitere

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26094224 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Tal Shahar Gabay und 17 weiteren Autor:innen. Beteiligte Einrichtung: Hematology Research Center, Clinical Research Institute at Rambam, Rambam Health Care Campus, Haifa 3109601, Israel. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Enhancer of Zeste Homolog 2 Protein, Hematopoietic Stem Cells, Tumor Suppressor Protein p53. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Israel Cancer Association, Israel Cancer Research Fund, European Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute myeloid leukemia (AML) is associated with unfavorable patient outcomes primarily related to disease relapse. Since specific types of leukemic hematopoietic stem and progenitor cells (HSPCs) are suggested to contribute to AML propagation, this study aimed to identify and explore relapse-initiating HSPC subpopulations present at diagnosis, using single-cell analysis (SCA). We developed unique high-resolution techniques capable of tracking single-HSPC-derived subclones during AML evolution. Each subclone was evaluated for chemo-resistance, in vivo leukemogenic potential, mutational profile, and the cell of origin. In BM samples of 15 AML patients, GMP-like and MLP-like HSPC subpopulations were identified as prevalent at relapse, exhibiting chemo-resistance to commonly used chemotherapy agents cytosine arabinoside (Ara-C) and daunorubicin. Reconstruction of phylogenetic lineage trees combined with genetic analysis of single HSPCs and single-HSPC-derived subclones demonstrated two distinct clusters, originating from MLP-like or GMP-like subpopulations, observed both at diagnosis and relapse. These subpopulations induced leukemia development ex vivo and in vivo. Genetic SCA showed that these relapse-related subpopulations harbored mutated EZH2 and TP53, detected already at diagnosis. This study, using combined molecular, functional, and genomic analyses at the level of single cells, identified patient-specific chemo-resistant HSPC subpopulations at the time of diagnosis, promoting AML relapse.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteEnhancer of Zeste Homolog 2 ProteinHematopoietic Stem CellsTumor Suppressor Protein p53MutationHumansSingle-Cell AnalysisAnimalsMaleFemaleMiddle AgedMiceRecurrenceAdultCytarabineDrug Resistance, NeoplasmAgedNeoplastic Stem Cells

Stichwörter der Autor:innen

acute myeloid leukemia (AML)hematopoietic stem and progenitor cells (HSPCs)leukemogenic potentialrelapsesingle cell analysis (SCA)

Substanzen

Enhancer of Zeste Homolog 2 ProteinTumor Suppressor Protein p53EZH2 protein, humanTP53 protein, humanCytarabine

Autor:innen und Institutionen

  • Hematology Research Center, Clinical Research Institute at Rambam, Rambam Health Care Campus, Haifa 3109601, Israel.
  • The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa 3109601, Israel.
  • Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot 761001, Israel.
  • Department of Immunology, Weizmann Institute of Science, Rehovot 761001, Israel.
  • Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa 3109601, Israel.

ORCID-Profile: Niv Rabhun, Yaara Neumeier, Natalia Evtiugina, Shlomit Yehudai-Resheff, Tsila Zuckerman

Förderung

  • Israel Cancer Association
  • Israel Cancer Research Fund
  • European Commission
  • Israel Cancer Research Foundation
  • EU-H2020-Health
  • Kenneth and Sally Leafman Appelbaum Discovery Fund

Zitieren

APA

Shahar Gabay, T., Stolero, N., Rabhun, N., Sabah, R., Raz, O., Neumeier, Y., Marx, Z., Tao, L., Biezuner, T., Amir, S., Adar, R., Levy, R., Chapal-Ilani, N., Evtiugina, N., Shlush, L. I., Shapiro, E., Yehudai-Resheff, S., & Zuckerman, T. (2025). GMP-like and MLP-like Subpopulations of Hematopoietic Stem and Progenitor Cells Harboring Mutated EZH2 and TP53 at Diagnosis Promote Acute Myeloid Leukemia Relapse: Data of Combined Molecular, Functional, and Genomic Single-Stem-Cell Analyses. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26094224

Vancouver

Shahar Gabay T, Stolero N, Rabhun N, Sabah R, Raz O, Neumeier Y, et al. GMP-like and MLP-like Subpopulations of Hematopoietic Stem and Progenitor Cells Harboring Mutated EZH2 and TP53 at Diagnosis Promote Acute Myeloid Leukemia Relapse: Data of Combined Molecular, Functional, and Genomic Single-Stem-Cell Analyses. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26094224

BibTeX
@article{ShaharGabay2025,
  author = {Shahar Gabay, Tal and Stolero, Nofar and Rabhun, Niv and Sabah, Rawan and Raz, Ofir and Neumeier, Yaara and Marx, Zipora and Tao, Liming and Biezuner, Tamir and Amir, Shiran and Adar, Rivka and Levy, Ron and Chapal-Ilani, Noa and Evtiugina, Natalia and Shlush, Liran I and Shapiro, Ehud and Yehudai-Resheff, Shlomit and Zuckerman, Tsila},
  title = {GMP-like and MLP-like Subpopulations of Hematopoietic Stem and Progenitor Cells Harboring Mutated EZH2 and TP53 at Diagnosis Promote Acute Myeloid Leukemia Relapse: Data of Combined Molecular, Functional, and Genomic Single-Stem-Cell Analyses},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26094224}
}
Kostenlos starten →